The most important risk factor for the development of sporadic Alzheimer's disease (AD) is ageing. Senescence accelerated mouse prone 8 (SAMP8) is a model of sporadic AD, with senescence accelerated resistant mouse (SAMR1) as a control. In this study, we aimed to determine the onset of senescence-induced neurodegeneration and the related potential therapeutic window using behavioral experiments, immunohistochemistry and western blotting in SAMP8 and SAMR1 mice at 3, 6 and 9 months of age. The Y-maze revealed significantly impaired working spatial memory of SAMP8 mice from the 6th month. With ageing, increasing plasma concentrations of proinflammatory cytokines in SAMP8 mice were detected as well as significantly increased astrocytosis in the cortex and microgliosis in the brainstem. Moreover, from the 3rd month, SAMP8 mice displayed a decreased number of neurons and neurogenesis in the hippocampus. From the 6th month, increased pathological phosphorylation of tau protein at Thr231 and Ser214 was observed in the hippocampi of SAMP8 mice. In conclusion, changes specific for neurodegenerative processes were observed between the 3rd and 6th month of age in SAMP8 mice; thus, potential neuroprotective interventions could be applied between these ages.

Institute of Microbiology of the Czech Academy of Sciences Prague 142 00 Czech Republic

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Prague 166 10 Czech Republic

Institute of Physiology of the Czech Academy of Sciences Prague 142 00 Czech Republic

Zobrazit více v PubMed

Sengoku R. Aging and Alzheimer’s disease pathology. Neuropathology. 2020; 40:22–9. 10.1111/neup.12626 PubMed DOI

Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J, Villegas S. Mouse Models of Alzheimer’s Disease. J Alzheimers Dis. 2017; 57:1171–83. 10.3233/JAD-170045 PubMed DOI

Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011; 1:a006189. 10.1101/cshperspect.a006189 PubMed DOI PMC

Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement. 2014; 10:S76–83. 10.1016/j.jalz.2013.12.010 PubMed DOI

Fakhoury M. Microglia and Astrocytes in Alzheimer’s Disease: Implications for Therapy. Curr Neuropharmacol. 2018; 16:508–18. 10.2174/1570159X15666170720095240 PubMed DOI PMC

Mengr A, Hrubá L, Exnerová A, Holubová M, Popelová A, Železná B, Kuneš J, Maletínská L. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study. Curr Alzheimer Res. 2021; 18:607–22. 10.2174/1567205018666210922110652 PubMed DOI

Montgomery SL, Narrow WC, Mastrangelo MA, Olschowka JA, O’Banion MK, Bowers WJ. Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies. Am J Pathol. 2013; 182:2285–97. 10.1016/j.ajpath.2013.02.030 PubMed DOI PMC

Gonçalves RA, Wijesekara N, Fraser PE, De Felice FG. The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies. Front Cell Neurosci. 2019; 13:17. 10.3389/fncel.2019.00017 PubMed DOI PMC

Kacířová M, Zmeškalová A, Kořínková L, Železná B, Kuneš J, Maletínská L. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer’s disease-like pathology? Clin Sci (Lond). 2020; 134:547–70. 10.1042/CS20191313 PubMed DOI

Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000; 908:244–54. 10.1111/j.1749-6632.2000.tb06651.x PubMed DOI

Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T. A new murine model of accelerated senescence. Mech Ageing Dev. 1981; 17:183–94. 10.1016/0047-6374(81)90084-1 PubMed DOI

Takeda T, Hosokawa M, Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp Gerontol. 1997; 32:105–9. 10.1016/s0531-5565(96)00036-8 PubMed DOI

Morley JE, Farr SA, Kumar VB, Armbrecht HJ. The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer’s disease. Curr Pharm Des. 2012; 18:1123–30. 10.2174/138161212799315795 PubMed DOI

Liu B, Liu J, Shi JS. SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer’s Disease. J Alzheimers Dis. 2020; 75:385–95. 10.3233/JAD-200063 PubMed DOI

Akiguchi I, Pallàs M, Budka H, Akiyama H, Ueno M, Han J, Yagi H, Nishikawa T, Chiba Y, Sugiyama H, Takahashi R, Unno K, Higuchi K, Hosokawa M. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda’s legacy and future directions. Neuropathology. 2017; 37:293–305. 10.1111/neup.12373 PubMed DOI

Sawano E, Negishi T, Aoki T, Murakami M, Tashiro T. Alterations in local thyroid hormone signaling in the hippocampus of the SAMP8 mouse at younger ages: association with delayed myelination and behavioral abnormalities. J Neurosci Res. 2013; 91:382–92. 10.1002/jnr.23161 PubMed DOI PMC

del Valle J, Bayod S, Camins A, Beas-Zárate C, Velázquez-Zamora DA, González-Burgos I, Pallàs M. Dendritic spine abnormalities in hippocampal CA1 pyramidal neurons underlying memory deficits in the SAMP8 mouse model of Alzheimer’s disease. J Alzheimers Dis. 2012; 32:233–40. 10.3233/JAD-2012-120718 PubMed DOI

Fujiwara Y, Takahashi H, Hirai K, Miyamoto M. Involvement of the glutamatergic system in behavioral disorders in senescence-accelerated mice (SAMP8). Int Congr Ser. 2004; 1260:303–8. 10.1016/S0531-5131(03)01730-8 DOI

Cuesta S, Kireev R, García C, Rancan L, Vara E, Tresguerres JA. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8). Age (Dordr). 2013; 35:659–71. 10.1007/s11357-012-9397-7 PubMed DOI PMC

Canudas AM, Gutierrez-Cuesta J, Rodríguez MI, Acuña-Castroviejo D, Sureda FX, Camins A, Pallàs M. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech Ageing Dev. 2005; 126:1300–4. 10.1016/j.mad.2005.07.008 PubMed DOI

Valero J, Bernardino L, Cardoso FL, Silva AP, Fontes-Ribeiro C, Ambrósio AF, Malva JO. Impact of Neuroinflammation on Hippocampal Neurogenesis: Relevance to Aging and Alzheimer’s Disease. J Alzheimers Dis. 2017; 60:S161–8. 10.3233/JAD-170239 PubMed DOI

Li G, Cheng H, Zhang X, Shang X, Xie H, Zhang X, Yu J, Han J. Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice. Neurol Sci. 2013; 34:963–9. 10.1007/s10072-012-1173-z PubMed DOI

Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, Pyke C, Knudsen LB, Farr SA, Vrang N. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease. J Alzheimers Dis. 2015; 46:877–88. 10.3233/JAD-143090 PubMed DOI PMC

Yan WW, Chen GH, Wang F, Tong JJ, Tao F. Long-term acarbose administration alleviating the impairment of spatial learning and memory in the SAMP8 mice was associated with alleviated reduction of insulin system and acetylated H4K8. Brain Res. 2015; 1603:22–31. 10.1016/j.brainres.2015.01.042 PubMed DOI

Jahn H. Memory loss in Alzheimer’s disease. Dialogues Clin Neurosci. 2013; 15:445–54. 10.31887/DCNS.2013.15.4/hjahn PubMed DOI PMC

Carola V, D’Olimpio F, Brunamonti E, Mangia F, Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res. 2002; 134:49–57. 10.1016/s0166-4328(01)00452-1 PubMed DOI

Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. Methods Mol Biol. 2019; 1916:105–11. 10.1007/978-1-4939-8994-2_10 PubMed DOI

Tsumagari R, Maruo K, Nakao T, Ueda S, Yamanoue M, Shirai Y. Motor Dyscoordination and Alteration of Functional Correlation Between DGKγ and PKCγ in Senescence-Accelerated Mouse Prone 8 (SAMP8). Front Aging Neurosci. 2021; 13:573966. 10.3389/fnagi.2021.573966 PubMed DOI PMC

Yanai S, Endo S. Early onset of behavioral alterations in senescence-accelerated mouse prone 8 (SAMP8). Behav Brain Res. 2016; 308:187–95. 10.1016/j.bbr.2016.04.026 PubMed DOI

Gong Y, Liu L, Xie B, Liao Y, Yang E, Sun Z. Ameliorative effects of lotus seedpod proanthocyanidins on cognitive deficits and oxidative damage in senescence-accelerated mice. Behav Brain Res. 2008; 194:100–7. 10.1016/j.bbr.2008.06.029 PubMed DOI

Lin N, Pan XD, Chen AQ, Zhu YG, Wu M, Zhang J, Chen XC. Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice. Behav Brain Res. 2014; 258:8–18. 10.1016/j.bbr.2013.10.010 PubMed DOI

Luheshi GN, Stefferl A, Turnbull AV, Dascombe MJ, Brouwer S, Hopkins SJ, Rothwell NJ. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-alpha in the rat. Am J Physiol. 1997; 272:R862–8. 10.1152/ajpregu.1997.272.3.R862 PubMed DOI

Sundgren-Andersson AK, Ostlund P, Bartfai T. IL-6 is essential in TNF-alpha-induced fever. Am J Physiol. 1998; 275:R2028–34. 10.1152/ajpregu.1998.275.6.R2028 PubMed DOI

Chouchani ET, Kazak L, Spiegelman BM. New Advances in Adaptive Thermogenesis: UCP1 and Beyond. Cell Metab. 2019; 29:27–37. 10.1016/j.cmet.2018.11.002 PubMed DOI

Yagi H, Irino M, Matsushita T, Katoh S, Umezawa M, Tsuboyama T, Hosokawa M, Akiguchi I, Tokunaga R, Takeda T. Spontaneous spongy degeneration of the brain stem in SAM-P/8 mice, a newly developed memory-deficient strain. J Neuropathol Exp Neurol. 1989; 48:577–90. 10.1097/00005072-198909000-00008 PubMed DOI

Rössler M, Zarski R, Bohl J, Ohm TG. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer’s disease. Acta Neuropathol. 2002; 103:363–9. 10.1007/s00401-001-0475-7 PubMed DOI

Gang B, Yue C, Han N, Xue H, Li B, Sun L, Li X, Zhao Q. Limited hippocampal neurogenesis in SAMP8 mouse model of Alzheimer’s disease. Brain Res. 2011; 1389:183–93. 10.1016/j.brainres.2011.03.039 PubMed DOI

Shonesy BC, Jalan-Sakrikar N, Cavener VS, Colbran RJ. CaMKII: a molecular substrate for synaptic plasticity and memory. Prog Mol Biol Transl Sci. 2014; 122:61–87. 10.1016/B978-0-12-420170-5.00003-9 PubMed DOI

Yan X, Liu J, Ye Z, Huang J, He F, Xiao W, Hu X, Luo Z. CaMKII-Mediated CREB Phosphorylation Is Involved in Ca2+-Induced BDNF mRNA Transcription and Neurite Outgrowth Promoted by Electrical Stimulation. PLoS One. 2016; 11:e0162784. 10.1371/journal.pone.0162784 PubMed DOI PMC

Kida S. A Functional Role for CREB as a Positive Regulator of Memory Formation and LTP. Exp Neurobiol. 2012; 21:136–40. 10.5607/en.2012.21.4.136 PubMed DOI PMC

de la Monte SM. Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease. Drugs. 2017; 77:47–65. 10.1007/s40265-016-0674-0 PubMed DOI PMC

Rhea EM, Banks WA. The SAMP8 mouse for investigating memory and the role of insulin in the brain. Exp Gerontol. 2017; 94:64–8. 10.1016/j.exger.2016.12.009 PubMed DOI PMC

Zhao WQ, Chen H, Quon MJ, Alkon DL. Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol. 2004; 490:71–81. 10.1016/j.ejphar.2004.02.045 PubMed DOI

Schubert M, Brazil DP, Burks DJ, Kushner JA, Ye J, Flint CL, Farhang-Fallah J, Dikkes P, Warot XM, Rio C, Corfas G, White MF. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci. 2003; 23:7084–92. 10.1523/JNEUROSCI.23-18-07084.2003 PubMed DOI PMC

Bhat NR, Thirumangalakudi L. Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. J Alzheimers Dis. 2013; 36:781–9. 10.3233/JAD-2012-121030 PubMed DOI PMC

Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer’s disease and diabetes. J Pathol. 2011; 225:54–62. 10.1002/path.2912 PubMed DOI PMC

Zhou XW, Gustafsson JA, Tanila H, Bjorkdahl C, Liu R, Winblad B, Pei JJ. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis. 2008; 31:386–94. 10.1016/j.nbd.2008.05.013 PubMed DOI

Yang Y, Jia X, Feng J, Wang Z, Cao Y, Liu J, Li H. Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation. Evid Based Complement Alternat Med. 2017; 2017:5934254. 10.1155/2017/5934254 PubMed DOI PMC

Zhang Z, Yang J, Liu C, Xie J, Qiu S, Yang X, Wu C. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer’s disease-type pathologies in SAMP8 mice. Pharmacol Res. 2019; 139:512–23. 10.1016/j.phrs.2018.10.024 PubMed DOI

DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009. (Suppl 2); 32:S157–63. 10.2337/dc09-S302 PubMed DOI PMC

Armoni M, Harel C, Karnieli E. Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation. Trends Endocrinol Metab. 2007; 18:100–7. 10.1016/j.tem.2007.02.001 PubMed DOI

Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I, Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem. 2004; 279:41114–23. 10.1074/jbc.M400674200 PubMed DOI

White JP, Puppa MJ, Gao S, Sato S, Welle SL, Carson JA. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. Am J Physiol Endocrinol Metab. 2013; 304:E1042–52. 10.1152/ajpendo.00410.2012 PubMed DOI PMC

Liu HW, Chan YC, Wei CC, Chen YA, Wang MF, Chang SJ. An alternative model for studying age-associated metabolic complications: Senescence-accelerated mouse prone 8. Exp Gerontol. 2017; 99:61–8. 10.1016/j.exger.2017.08.023 PubMed DOI

Wang YY, Zhou N, Si YP, Bai ZY, Li M, Feng WS, Zheng XK. A UPLC-Q-TOF/MS-Based Metabolomics Study on the Effect of Corallodiscus flabellatus (Craib) B. L. Burtt Extract on Alzheimer's Disease. Evid Based Complement Alternat Med. 2021; 2021:8868690. 10.1155/2021/8868690 PubMed DOI PMC

Currais A, Farrokhi C, Dargusch R, Armando A, Quehenberger O, Schubert D, Maher P. Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse. J Gerontol A Biol Sci Med Sci. 2018; 73:299–307. 10.1093/gerona/glx104 PubMed DOI PMC

Fu C, Yang Y, Kumrungsee T, Kimoto A, Izu H, Kato N. Low-Dose Ethanol Has Impacts on Plasma Levels of Metabolites Relating to Chronic Disease Risk in SAMP8 mice. J Nutr Sci Vitaminol (Tokyo). 2020; 66:553–60. 10.3177/jnsv.66.553 PubMed DOI

Tian H, Li S, Wen H, Zhang X, Li J. Volatile organic compounds fingerprinting in faeces and urine of Alzheimer’s disease model SAMP8 mice by headspace-gas chromatography-ion mobility spectrometry and headspace-solid phase microextraction-gas chromatography-mass spectrometry. J Chromatogr A. 2020; 1614:460717. 10.1016/j.chroma.2019.460717 PubMed DOI

Jiang N, Yan X, Zhou W, Zhang Q, Chen H, Zhang Y, Zhang X. NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse. J Proteome Res. 2008; 7:3678–86. 10.1021/pr800439b PubMed DOI

Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, Bianchi M, Ulrich P, Cerami A, Sherry B, Tracey KJ. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response. J Exp Med. 1997; 185:1759–68. 10.1084/jem.185.10.1759 PubMed DOI PMC

Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, Bendlin BB, Rey FE. Gut microbiome alterations in Alzheimer’s disease. Sci Rep. 2017; 7:13537. 10.1038/s41598-017-13601-y PubMed DOI PMC

Zeisel SH, Wishnok JS, Blusztajn JK. Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Ther. 1983; 225:320–4. PubMed

Vogt NM, Romano KA, Darst BF, Engelman CD, Johnson SC, Carlsson CM, Asthana S, Blennow K, Zetterberg H, Bendlin BB, Rey FE. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease. Alzheimers Res Ther. 2018; 10:124. 10.1186/s13195-018-0451-2 PubMed DOI PMC

Adesso S, Magnus T, Cuzzocrea S, Campolo M, Rissiek B, Paciello O, Autore G, Pinto A, Marzocco S. Indoxyl Sulfate Affects Glial Function Increasing Oxidative Stress and Neuroinflammation in Chronic Kidney Disease: Interaction between Astrocytes and Microglia. Front Pharmacol. 2017; 8:370. 10.3389/fphar.2017.00370 PubMed DOI PMC

Dong Y, Digman MA, Brewer GJ. Age- and AD-related redox state of NADH in subcellular compartments by fluorescence lifetime imaging microscopy. Geroscience. 2019; 41:51–67. 10.1007/s11357-019-00052-8 PubMed DOI PMC

Ghosh D, LeVault KR, Barnett AJ, Brewer GJ. A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J Neurosci. 2012; 32:5821–32. 10.1523/JNEUROSCI.6192-11.2012 PubMed DOI PMC

Dalmasso MC, Aran M, Galeano P, Perin S, Giavalisco P, Adami PMV, Castano EM, Vueloo AC, Scherer M, Maier W, Wagner M, Reidel-Heller S, Ramirez A, et al.. Nicotinamide as potential biomarker for Alzheimer’s disease: a translational study based on metabolomics. Research Square. 2021. [Epub ahead of print]. 10.21203/rs.3.rs-518284/v1 PubMed DOI PMC

Ringeissen S, Connor SC, Brown HR, Sweatman BC, Hodson MP, Kenny SP, Haworth RI, McGill P, Price MA, Aylott MC, Nunez DJ, Haselden JN, Waterfield CJ. Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography. Biomarkers. 2003; 8:240–71. 10.1080/1354750031000149124 PubMed DOI

Stienstra R, Mandard S, Patsouris D, Maass C, Kersten S, Müller M. Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation. Endocrinology. 2007; 148:2753–63. 10.1210/en.2007-0014 PubMed DOI

Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007; 29:99–108. 10.1152/physiolgenomics.00194.2006 PubMed DOI

Pelantová H, Bugáňová M, Holubová M, Šedivá B, Zemenová J, Sýkora D, Kaválková P, Haluzík M, Železná B, Maletínská L, Kuneš J, Kuzma M. Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination. Mol Cell Endocrinol. 2016; 431:88–100. 10.1016/j.mce.2016.05.003 PubMed DOI

Pelantová H, Bártová S, Anýž J, Holubová M, Železná B, Maletínská L, Novák D, Lacinová Z, Šulc M, Haluzík M, Kuzma M. Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity. Anal Bioanal Chem. 2016; 408:567–78. 10.1007/s00216-015-9133-0 PubMed DOI

Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab (Lond). 2010; 7:30. 10.1186/1743-7075-7-30 PubMed DOI PMC

Gualano B, Artioli GG, Poortmans JR, Lancha Junior AH. Exploring the therapeutic role of creatine supplementation. Amino Acids. 2010; 38:31–44. 10.1007/s00726-009-0263-6 PubMed DOI

Brewer GJ, Wallimann TW. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem. 2000; 74:1968–78. 10.1046/j.1471-4159.2000.0741968.x PubMed DOI

Foy CM, Daly EM, Glover A, O’Gorman R, Simmons A, Murphy DG, Lovestone S. Hippocampal proton MR spectroscopy in early Alzheimer’s disease and mild cognitive impairment. Brain Topogr. 2011; 24:316–22. 10.1007/s10548-011-0170-5 PubMed DOI

Kacířová M, Železná B, Blažková M, Holubová M, Popelová A, Kuneš J, Šedivá B, Maletínská L. Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22. J Neuroinflammation. 2021; 18:141. 10.1186/s12974-021-02190-3 PubMed DOI PMC

Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, Gourdy P. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020; 63:453–61. 10.1007/s00125-019-05040-3 PubMed DOI PMC

Pražienková V, Funda J, Pirník Z, Karnošová A, Hrubá L, Kořínková L, Neprašová B, Janovská P, Benzce M, Kadlecová M, Blahoš J, Kopecký J, Železná B, et al.. GPR10 gene deletion in mice increases basal neuronal activity, disturbs insulin sensitivity and alters lipid homeostasis. Gene. 2021; 774:145427. 10.1016/j.gene.2021.145427 PubMed DOI

Holubová M, Hrubá L, Popelová A, Bencze M, Pražienková V, Gengler S, Kratochvílová H, Haluzík M, Železná B, Kuneš J, Hölscher C, Maletínská L. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology. Neuropharmacology. 2019; 144:377–87. 10.1016/j.neuropharm.2018.11.002 PubMed DOI

Franklin K, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press. 2008.

Pelantová H, Bugáňová M, Anýž J, Železná B, Maletínská L, Novák D, Haluzík M, Kuzma M. Strategy for NMR metabolomic analysis of urine in mouse models of obesity--from sample collection to interpretation of acquired data. J Pharm Biomed Anal. 2015; 115:225–35. 10.1016/j.jpba.2015.06.036 PubMed DOI

Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem. 2006; 78:4281–90. 10.1021/ac051632c PubMed DOI

Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS, Xia J. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018; 46:W486–94. 10.1093/nar/gky310 PubMed DOI PMC

Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice